Literature DB >> 24910357

A Spanish version of the Skin Cancer Index: a questionnaire for measuring quality of life in patients with cervicofacial nonmelanoma skin cancer.

M de Troya-Martín1, F Rivas-Ruiz, N Blázquez-Sánchez, I Fernández-Canedo, M Aguilar-Bernier, J B Repiso-Jiménez, J C Toribio-Montero, M Jones-Caballero, J Rhee.   

Abstract

INTRODUCTION: The Skin Cancer Index (SCI) is the first specific patient-reported outcome measure for patients with cervicofacial nonmelanoma skin cancer. To date, only the original English version has been published.
OBJECTIVES: To develop a Spanish version of the SCI that is semantically and linguistically equivalent to the original, and to evaluate its measurement properties in this different cultural environment.
MATERIAL AND METHODS: A cross-sectional study was conducted of the cultural adaptation and empirical validation of the questionnaire, analysing the psychometric properties of the new index at different stages.
RESULTS: Of 440 patients recruited to the study, 431 (95%) completed the Spanish version of the SCI questionnaire, in a mean time of 6·3 min (SD 2·9). Factor analysis of the scale revealed commonality and loading values of < 0·5 for three of the 15 items. The remaining 12 items converged into two components: appearance/social aspects (seven items) and emotional aspects (five items). Both domains presented a high level of internal consistency, with Cronbach's alpha values above 0·8. The convergent-discriminant validity analysis produced correlations higher than 0·3 for the mental component of the Short Form Health Survey-12v2 Health Questionnaire (correlation coefficient 0·39) and the Dermatology Quality of Life Index (correlation coefficient -0·30). In the test-retest, nine of the 12 items produced a weighted kappa value exceeding 0·4, and for the remaining three items, the absolute agreement percentage exceeded 60%.
CONCLUSIONS: The Spanish version of the SCI quality of life scale has been satisfactorily adapted and validated for use in Spanish-speaking countries and populations.
© 2014 British Association of Dermatologists.

Entities:  

Mesh:

Year:  2014        PMID: 24910357     DOI: 10.1111/bjd.13173

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  3 in total

1.  Comparison of the Skin Cancer Quality of Life Impact Tool and the Skin Cancer Index Questionnaire in Measurement of Health-Related Quality of Life and the Effect of Patient Education Brochures in Patients with Actinic Keratosis, Non-melanoma, and Cutaneous Melanoma.

Authors:  Sam El Abbadi; Laura Susok; Egger Stockfleth; Falk Georges Bechara; Thilo Gambichler; Swetlana Herbrandt; Lisa Goldschmidtböing; Michael Sand
Journal:  Dermatol Ther (Heidelb)       Date:  2021-04-13

2.  Quality of Life During Treatment for Cervicofacial Non-melanoma Skin Cancer.

Authors:  Pablo García-Montero; María Victoria de Gálvez-Aranda; Nuria Blázquez-Sánchez; Francisco Rivas-Ruíz; José Francisco Millán-Cayetano; Cristina García-Harana; Magdalena de Troya Martín
Journal:  J Cancer Educ       Date:  2022-02       Impact factor: 2.037

3.  Responsiveness of the Spanish Version of the "Skin Cancer Index".

Authors:  M de Troya-Martín; F Rivas-Ruiz; N Blázquez-Sánchez; I Fernández-Canedo; M Aguilar-Bernier; J B Repiso-Jiménez; J C Toribio-Montero; M Jones-Caballero; J Rhee
Journal:  J Skin Cancer       Date:  2016-10-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.